Human Tissue Authority

The regulator for human tissue and organs

How to provide a third party with the authority to undertake licensable activities on behalf of a licensed establishment
  • Third party
This section explains the consent exemptions from the Human Tissue Act (2004)
  • Consent
Guidance on paragraphs 194-196 of the HTA’s Code of Practice on the Human Transplantation (Wales) Act 2013 - Persons who Lack Capacity to Consent
  • Deceased donation
  • Wales
HTA position on biological testing requirements for autologous donors of tissues and cells.
  • Autologous donors
New EU regulations for medical devices (MDR) and in-vitro medical devices (IVDR) have been introduced. These regulations entered into force on 25 May 2017 across EU Member States. However, most requirements will not fully apply until 26 May 2020 for the MDR, and 26 May 2022 for the IVDR.The scope of the MDR now includes certain products manufactured utilising derivatives of tissues or cells of...
  • Advanced Therapy Medicinal Products
  • EU tissue and cells directive
  • Human application
Information for regional resilience teams on licensing of emergency mortuaries.
  • Emergency mortuaries
  • General licensing
  • Mortuaries
  • Post mortem
The transportation and delivery of tissues or cells intended for human application, including to or from other countries
  • Import and export
Position statement jointly produced and issued by the Human Tissue Authority (HTA) and the Health Research Authority (HRA).
  • Diagnostic archives
Regulation regarding cells procured from a person and processed during a single surgical procedure
  • Single surgical procedures
Position statement on extending existing licences to cover the removal of tissue from the deceased for research
  • Licensing
  • Removal licence
  • Research